TY - JOUR
T1 - Synthesis, α-glucosidase inhibitory activity, and molecular docking of cinnamamides
AU - Aijijiyah, Nur Pasca
AU - Wati, First Ambar
AU - Rahayu, Reni
AU - Srilistiani, Alfatchu
AU - Mahzumi, Farah
AU - Aulia, Tinezsia
AU - Santoso, Liangga
AU - Pamela, Egar
AU - Ramadhani, Ersya Yanu
AU - Ilfahmi, Yan Alamanda
AU - Purnomo, Adi Setyo
AU - Putra, Surya Rosa
AU - Santoso, Eko
AU - Ningsih, Sri
AU - Firdausi, Nisrina
AU - Santoso, Mardi
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2023/4
Y1 - 2023/4
N2 - Suitably substituted cinnamamides (3a-n) were successfully synthesized and tested for α-glucosidase inhibitory activity. Nine of the synthesized cinnamamides (3a-f, k-m) displayed moderate inhibitory activity, which was better than acarbose (IC50 = 185.00 ± 9.4 µM), with IC50 values ranging from 44.43 ± 5.7 to 91.14 ± 11.4 µM. Their α-glucosidase inhibitory activity greatly depended on their structure with electron-withdrawing groups on the cinnamoyl aromatic ring causing increased inhibition activity. According to the in vitro assay results, compound 3b with p-dimethylamino on the cinnamoyl ring has the best α-glucosidase inhibitory activity. The new synthesized cinnamamides (3b-i) showed acceptable physicochemical and pharmacokinetics characteristics with little toxicity indicating their potential use as lead drug candidates. Molecular docking studies of compound 3b (binding energy −8.33 kcal/mol) revealed that it interacted with His626 and two catalytic residues of α-glucosidase, namely Asp469 and Asp568. Overall, these cinnamamides show potential as lead structures for further optimization as α-glucosidase inhibitors. Graphical Abstract: [Figure not available: see fulltext.]
AB - Suitably substituted cinnamamides (3a-n) were successfully synthesized and tested for α-glucosidase inhibitory activity. Nine of the synthesized cinnamamides (3a-f, k-m) displayed moderate inhibitory activity, which was better than acarbose (IC50 = 185.00 ± 9.4 µM), with IC50 values ranging from 44.43 ± 5.7 to 91.14 ± 11.4 µM. Their α-glucosidase inhibitory activity greatly depended on their structure with electron-withdrawing groups on the cinnamoyl aromatic ring causing increased inhibition activity. According to the in vitro assay results, compound 3b with p-dimethylamino on the cinnamoyl ring has the best α-glucosidase inhibitory activity. The new synthesized cinnamamides (3b-i) showed acceptable physicochemical and pharmacokinetics characteristics with little toxicity indicating their potential use as lead drug candidates. Molecular docking studies of compound 3b (binding energy −8.33 kcal/mol) revealed that it interacted with His626 and two catalytic residues of α-glucosidase, namely Asp469 and Asp568. Overall, these cinnamamides show potential as lead structures for further optimization as α-glucosidase inhibitors. Graphical Abstract: [Figure not available: see fulltext.]
KW - Acarbose
KW - Cinnamamides
KW - Molecular docking
KW - α-Glucosidase inhibitory activity
UR - http://www.scopus.com/inward/record.url?scp=85148077106&partnerID=8YFLogxK
U2 - 10.1007/s00044-023-03032-y
DO - 10.1007/s00044-023-03032-y
M3 - Article
AN - SCOPUS:85148077106
SN - 1054-2523
VL - 32
SP - 723
EP - 735
JO - Medicinal Chemistry Research
JF - Medicinal Chemistry Research
IS - 4
ER -